Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Machine learning can accurately identify Alopecia Areata, aiding in early detection and treatment of this hair loss condition.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Vitamins A, B, C, and D are important for skin health and are being explored for new uses, but more research is needed to confirm their effectiveness.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

COVID-19 can cause hair loss and nail changes in some patients.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

Androgenetic alopecia severity does not affect COVID-19 severity.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

Zinc chloride can cause human scalp cells to multiply and die.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

Combining two treatments for hair loss works better than using just one.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

Post-COVID-19 hair loss is likely due to stress and inflammation.

Women with PCOS often have different clinical signs, hormone levels, and gynecological issues compared to those without the condition.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.

Androgens play a key role in causing alopecia by changing the hair growth cycle.

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.